Cantel Medical
CMD
CMD was delisted on the 1st of June, 2021.
254 hedge funds and large institutions have $2.47B invested in Cantel Medical in 2019 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 101 increasing their positions, 80 reducing their positions, and 30 closing their positions.
36% more capital inflows, than outflows
Capital inflows: $300M | Capital outflows: $220M
29% more call options, than puts
Call options by funds: $2.29M | Put options by funds: $1.77M
26% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 80
13% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 30
2.47% more ownership
Funds ownership: 86.13% → 88.6% (+2.5%)
0% more funds holding
Funds holding: 253 → 254 (+1)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Champlain Investment Partners
Burlington,
Vermont
|
+$62.3M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$42.9M |
| 3 |
Riverbridge Partners
Minneapolis,
Minnesota
|
+$24.6M |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$24.2M |
| 5 |
Select Equity Group
New York
|
+$17.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$38.8M |
| 2 |
Ranger Investment Management
Dallas,
Texas
|
-$26.1M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$15.7M |
| 4 |
Diker Management
New York
|
-$14.9M |
| 5 |
BlackRock
New York
|
-$14M |
CMD Hedge Fund Activity: Q1 2019 in Review
254 of the 4,635 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical (CMD) for Q1 2019, worth a combined $2.47B — down 7.6% from $2.68B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CMD positions and 30 closed out — a net gain of 4 holders — while 101 added to existing stakes and 80 trimmed.
The largest buyer was Champlain Investment Partners, adding an estimated $62.3M. The largest seller was Invesco, cutting an estimated $38.8M.
- 254 institutional investors held Cantel Medical (CMD) as of Q1 2019, up from 253 in Q4 2018.
- Funds reported $2.47B of Cantel Medical stock for Q1 2019, down 7.6% quarter-over-quarter.
- 34 funds opened new Cantel Medical positions in Q1 2019 and 30 closed out, a net change of +4 holders.
- The largest Cantel Medical buyer in Q1 2019 was Champlain Investment Partners, an estimated $62.3M added.
- The largest Cantel Medical seller in Q1 2019 was Invesco, an estimated $38.8M sold.
Based on aggregated 13F filings for Q1 2019.